Team:USTC CHINA/Safety
From 2013.igem.org
(Difference between revisions)
(16 intermediate revisions not shown) | |||
Line 4: | Line 4: | ||
<link rel="stylesheet" type="text/css" href="https://2013.igem.org/Team:USTC_CHINA/main.css?action=raw&ctype=text/css" /> | <link rel="stylesheet" type="text/css" href="https://2013.igem.org/Team:USTC_CHINA/main.css?action=raw&ctype=text/css" /> | ||
<style type="text/css"> | <style type="text/css"> | ||
- | + | .basic-bar h2{font-size:24px;} | |
+ | .basic-bar h3{font-size:18px;font-height:28px;} | ||
+ | .basic-bar p{font-size:16px;} | ||
</style> | </style> | ||
</head> | </head> | ||
Line 12: | Line 14: | ||
<div id="igemlogo"><a href="https://2013.igem.org/Main_Page" target="_blank"><img src="https://static.igem.org/mediawiki/2013/2/26/2013ustcigem_IGEM_basic_Logo.png" alt="igem home page" width="50" height="40" /></a></div> | <div id="igemlogo"><a href="https://2013.igem.org/Main_Page" target="_blank"><img src="https://static.igem.org/mediawiki/2013/2/26/2013ustcigem_IGEM_basic_Logo.png" alt="igem home page" width="50" height="40" /></a></div> | ||
- | + | <ul id="nav"> | |
<li><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a></li> | <li><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a></li> | ||
- | <li | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Overview">Project</a> |
<ul class="subs"> | <ul class="subs"> | ||
<li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Overview">Overview</a></li> | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Overview">Overview</a></li> | ||
- | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/ | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Background">Background</a></li> |
+ | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Design">Design</a></li> | ||
<li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Results</a></li> | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Project/Results">Results</a></li> | ||
- | <li><a href="https://2013.igem.org/Team:USTC_CHINA | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Parts">Parts</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 30: | Line 33: | ||
<li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/">Modeling</a> | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/">Modeling</a> | ||
<ul class="subs"> | <ul class="subs"> | ||
- | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/ | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/KillSwitch">Kill Switch</a></li> |
<li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/B.SubtilisCulture">B.Subtilis Culture</a></li> | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/B.SubtilisCulture">B.Subtilis Culture</a></li> | ||
- | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/ | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Modeling/DesignsofImmuneExperiments">Designs of Immune Experiments</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 45: | Line 48: | ||
<li><a href="https://2013.igem.org/Team:USTC_CHINA/Team">Members</a></li> | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Team">Members</a></li> | ||
<li><a href="https://igem.org/Team.cgi?year=2013&team_name=USTC_CHINA">Profile</a></li> | <li><a href="https://igem.org/Team.cgi?year=2013&team_name=USTC_CHINA">Profile</a></li> | ||
- | <li><a href="https://2013.igem.org/Team:USTC_CHINA/ | + | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Attributions">Attributions</a></li> |
- | <li><a href="https:// | + | <li><a href="https://igem.org/2013_Judging_Form?id=1074#iGEM_Medals">Achievements</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
- | <li><a href="https://2013.igem.org/Team:USTC_CHINA/Safety">Safety</a></li> | + | <li class="active"><a href="https://2013.igem.org/Team:USTC_CHINA/Safety">Safety</a></li> |
</ul> | </ul> | ||
<div id="tlogo"><img src="https://static.igem.org/mediawiki/2013/f/f8/2013ustc-china_T-VACCINE.png" width="100%" height="123" /> | <div id="tlogo"><img src="https://static.igem.org/mediawiki/2013/f/f8/2013ustc-china_T-VACCINE.png" width="100%" height="123" /> | ||
Line 58: | Line 61: | ||
<div class="content" align="center"> | <div class="content" align="center"> | ||
<div class="conbar1"> | <div class="conbar1"> | ||
- | <div id="breadcrumb"><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a> > <a href="https://2013.igem.org/Team:USTC_CHINA/ | + | <div id="breadcrumb"><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a> > <a href="https://2013.igem.org/Team:USTC_CHINA/Safety">Safety</a> </div></div> |
<div class="conbar2"> | <div class="conbar2"> | ||
<div class="leftbar" align="left"> | <div class="leftbar" align="left"> | ||
- | <div class=" | + | <div class="basic-bar"> |
- | + | <h2>Project Safety</h2> | |
- | + | <h3>Would any of your project ideas raise safety issues in terms of researcher safety,public safety or environmental safety?</h3> | |
- | + | <p align="justify">To ensure biosafety, we design a <a href="https://2013.igem.org/Team:USTC_CHINA/Project/Design" target="_blank" >kill switch</a> in <i>Bacillus</i> for the first time in iGEM. The very type <i>B.subtilis</i>, which contains kill switch circuit, can elimate their siblings and commit suicide when the switch is activated, and thus prevent gene contamination and raise project safty in terms of researcher safety, public safety and environmental safety.</p> | |
- | < | + | <br><br> |
- | < | + | <h2>Parts Safety</h2> |
- | + | <h3>Do any of the new BioBrick part (or devices) that you made this year raise any safety issues?</h3> | |
- | The only safety issue associated with our new BioBrick parts is researcher safety in testing the parts. We've revised a strict Lab operation standard to raise safty. | + | <p align="justify">The only safety issue associated with our new BioBrick parts is researcher safety in testing the parts. We've revised a strict Lab operation standard to raise safty.<br> |
- | < | + | </p> |
- | < | + | <br><br> |
- | + | <h2>Safty Supervision</h2> | |
- | + | <h3>Is there a local biosafety group, committee, or review board at your institution? </h3> | |
- | < | + | <p align="justify">Yes.Supervised by biosafety committee,we accepted their advice and abandoned intention to use HBV genome as template to amplify HBsAg antigen. With their help,we obtained plasmid fused HBsAg antigen eventually.</p> |
- | + | <br><br> | |
- | < | + | |
- | + | ||
- | + | ||
</div> | </div> | ||
</div> | </div> | ||
Line 84: | Line 84: | ||
<div class="port-sidebar-border"><h>Download Safety Form</h></div> | <div class="port-sidebar-border"><h>Download Safety Form</h></div> | ||
<div class="clear"></div> | <div class="clear"></div> | ||
- | <div | + | <br> |
- | < | + | <div align="left"> |
- | < | + | <h4><a href="https://static.igem.org/mediawiki/2013/9/97/2013ustc-china_Basic_Safety_Form.pdf">iGEM 2013 Basic Safety Form.pdf</a></h4> |
- | < | + | <h4><a href="https://static.igem.org/mediawiki/2013/e/e0/2013ustc-china_Basic_Safety_Form_advisor%60s_signature.pdf">iGEM 2013 Basic Safety Form advisor`s signature.pdf</a></h4> |
+ | <h4><a href="https://static.igem.org/mediawiki/2013/c/c7/2013ustc-china_Biosafety_Form_Part_2.pdf">iGEM 2013 Biosafety Form Part 2.pdf</a></h4> | ||
+ | <h4><a href="https://static.igem.org/mediawiki/2013/f/f0/2013ustc-china_Biosafety_Form_Part_2_advisor%C2%B7s_signature.pdf">iGEM 2013 Biosafety Form Part 2 advisor`s signature.pdf</a></h4> | ||
+ | </div> | ||
</div></div></div> | </div></div></div> |
Latest revision as of 12:37, 28 October 2013